- Home
- GRFS vs BIPC Comparison
GRFS vs BIPC Comparison
Compare GRFS & BIPC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GRFS | BIPC |
|---|---|---|
| Founded | 1940 | 2019 |
| Country | Spain | United States |
| Employees | 25247 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Marine Transportation |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.4B | 4.6B |
| IPO Year | N/A | 2019 |
Fundamental Metrics
Financial Performance| Metric | GRFS | BIPC |
|---|---|---|
| Price | $7.64 | $40.41 |
| Analyst Decision | Hold | Sell |
| Analyst Count | 2 | 1 |
| Target Price | $10.15 | ★ $45.00 |
| AVG Volume (30 Days) | 569.0K | ★ 975.7K |
| Earning Date | 07-28-2022 | 04-29-2026 |
| Dividend Yield | 1.80% | ★ 5.13% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $4.49 | $7.85 |
| Revenue Next Year | $6.42 | $5.94 |
| P/E Ratio | $18.67 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $7.26 | $34.18 |
| 52 Week High | $11.14 | $51.72 |
Technical Indicators
Market Signals| Indicator | GRFS | BIPC |
|---|---|---|
| Relative Strength Index (RSI) | 47.21 | 45.04 |
| Support Level | $7.64 | $39.00 |
| Resistance Level | $8.24 | $41.08 |
| Average True Range (ATR) | 0.18 | 1.11 |
| MACD | -0.01 | -0.13 |
| Stochastic Oscillator | 44.02 | 0.40 |
Price Performance
Historical ComparisonAbout GRFS Grifols S.A.
Grifols SA is a healthcare company engaged in activities related to plasma-derived products and diagnostic solutions. The group has four reportable segments: Biopharma, Diagnostic, Bio Supplies, and Others. The Biopharma segment focuses on products derived from human plasma for therapeutic use, while the Diagnostic segment includes the marketing of diagnostic testing equipment and reagents. The Bio Supplies segment covers biological products for non-therapeutic use and plasma sales to third parties, and the Others segment includes manufacturing services, research activities, and complementary pharmaceutical products.
About BIPC Brookfield Infrastructure Corporation
Brookfield Infrastructure Corp is an indirect subsidiary of the partnership of the diversified infrastructure owner and operators. Its business is comprised of a U.K. regulated distribution operation, a Brazilian regulated natural gas transmission operation and an international intermodal logistics operation. Geographically, the company generates a majority of its revenue from Brazil and rest from United Kingdom, United States, France, Switzerland, Singapore, China, Denmark, Hong Kong, Germany and Others.